Bioventus (BVS) Net Cash Flow Growth (1y) (2021 - 2026)
Powered by 
Analysis
Bioventus (BVS) Net Cash Flow Growth (1y) (2021 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | -562.77% |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | -9.88% |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 83.30% |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 2,827.78% |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | -395.56% |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 168.38% |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | -593.75% |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | -103.49% |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | -54.17% |
| 10 | Bioventus | 923.70 Mn | 894.24 Mn | 105.67 Mn | -160.76% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 27, 2026 | -160.76% |
| Mar 28, 2026 | 23.04% |
| Dec 31, 2025 | 1,465.85% |
| Sep 27, 2025 | -9.10% |
| Jun 28, 2025 | 36.82% |
| Mar 29, 2025 | -70.80% |
| Dec 31, 2024 | -94.15% |
| Sep 28, 2024 | 600.19% |
| Jun 29, 2024 | 212.30% |
| Mar 30, 2024 | -166.26% |
| Dec 31, 2023 | 371.59% |
| Sep 30, 2023 | 66.75% |
| Jul 1, 2023 | 84.44% |
| Apr 1, 2023 | 202.94% |
| Dec 31, 2022 | 88.71% |
| Oct 1, 2022 | 8.12% |
| Jul 2, 2022 | -583.78% |
| Apr 2, 2022 | -138.49% |
| Dec 31, 2021 | -329.85% |
| Oct 2, 2021 | 87.05% |